Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

被引:155
作者
Wang, Li-Tzu [1 ,2 ]
Ting, Chiao-Hsuan [1 ]
Yen, Men-Luh [3 ,4 ]
Liu, Ko-Jiunn [5 ]
Sytwu, Huey-Kang [2 ,6 ]
Wu, Kenneth K. [1 ,7 ]
Yen, B. Linju [1 ]
机构
[1] Natl Hlth Res Inst, Inst Cellular & Syst Med, Regenerat Med Res Grp, 35 Keyan Rd, Zhunan 35053, Taiwan
[2] NDMC, Grad Inst Life Sci, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Ob Gyn, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[5] NHRI, Natl Inst Canc Res, Tainan, Taiwan
[6] NDMC, Grad Inst Microbiol & Immunol, Taipei, Taiwan
[7] China Med Coll, Grad Inst Basic Med Sci, Taichung, Taiwan
关键词
Mesenchymal stem cells; Human; Immunomodulation; Inflammation; Clinical trials; Autoimmune disease; Organ transplantation and rejection; Stem cell therapy; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALLERGIC AIRWAY INFLAMMATION; DSS-INDUCED COLITIS; STROMAL CELLS; MOUSE MODEL; CROHNS-DISEASE; IN-VITRO; LYMPHOCYTE-PROLIFERATION;
D O I
10.1186/s12929-016-0289-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that have been shown to possess immunomodulatory properties in recent years. Initially met with much skepticism, MSC immunomodulation has now been well reproduced across tissue sources and species to be clinically relevant. This has opened up the use of these versatile cells for application as 3rd party/allogeneic use in cell replacement/tissue regeneration, as well as for immune-and inflammation-mediated disease entities. Most surprisingly, use of MSCs for in immune-/inflammation-mediated diseases appears to yield more efficacy than for regenerative medicine, since engraftment of the exogenous cell does not appear necessary. In this review, we focus on this non-traditional clinical use of a tissue-specific stem cell, and highlight important findings and trends in this exciting area of stem cell therapy.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 148 条
[61]   Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients [J].
Introna, Martino ;
Lucchini, Giovanna ;
Dander, Erica ;
Galimberti, Stefania ;
Rovelli, Attilio ;
Balduzzi, Adriana ;
Longoni, Daniela ;
Pavan, Fabio ;
Masciocchi, Francesca ;
Algarotti, Alessandra ;
Mico, Caterina ;
Grassi, Anna ;
Deola, Sara ;
Cavattoni, Irene ;
Gaipa, Giuseppe ;
Belotti, Daniela ;
Perseghin, Paolo ;
Parma, Matteo ;
Pogliani, Enrico ;
Golay, Josee ;
Pedrini, Olga ;
Capelli, Chiara ;
Cortelazzo, Sergio ;
D'Amico, Giovanna ;
Biondi, Andrea ;
Rambaldi, Alessandro ;
Biagi, Ettore .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (03) :375-381
[62]   Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action [J].
Ionescu, Lavinia ;
Byrne, Roisin N. ;
van Haaften, Tim ;
Vadivel, Arul ;
Alphonse, Rajesh S. ;
Rey-Parra, Gloria J. ;
Weissmann, Gaia ;
Hall, Adam ;
Eaton, Farah ;
Thebaud, Bernard .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2012, 303 (11) :L967-L977
[63]   Placenta-Derived Mesenchymal Stem Cells Have an Immunomodulatory Effect That Can Control Acute Graft-Versus-Host Disease in Mice [J].
Jang, Moon Ju ;
Kim, Hye-Sun ;
Lee, Hye-Gyn ;
Kim, Gi Jin ;
Jeon, Hwang Gyun ;
Shin, Hyun-Soo ;
Chang, Sei-Kyung ;
Hur, Gin-Hyung ;
Chong, So Young ;
Oh, Doyeun ;
Chung, Hyung-Min .
ACTA HAEMATOLOGICA, 2013, 129 (04) :197-206
[64]   Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease [J].
Jang, Yun Kyung ;
Kim, Miyeon ;
Lee, Young-Ho ;
Oh, Wonil ;
Yang, Yoon Sun ;
Choi, Soo Jin .
CYTOTHERAPY, 2014, 16 (03) :298-308
[65]   Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells [J].
Jiang, XX ;
Zhang, Y ;
Liu, B ;
Zhang, SX ;
Wu, Y ;
Yu, XD ;
Mao, N .
BLOOD, 2005, 105 (10) :4120-4126
[66]   Intra-Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof-of-Concept Clinical Trial [J].
Jo, Chris Hyunchul ;
Lee, Young Gil ;
Shin, Won Hyoung ;
Kim, Hyang ;
Chai, Jee Won ;
Jeong, Eui Cheol ;
Kim, Ji Eun ;
Shim, Hackjoon ;
Shin, Ji Sun ;
Shin, Il Seob ;
Ra, Jeong Chan ;
Oh, Sohee ;
Yoon, Kang Sup .
STEM CELLS, 2014, 32 (05) :1254-1266
[67]   Paracrine Factors of Multipotent Stromal Cells Ameliorate Lung Injury in an Elastase-induced Emphysema Model [J].
Katsha, Ahmed M. ;
Ohkouchi, Shinya ;
Xin, Hong ;
Kanehira, Masahiko ;
Sun, Ruowen ;
Nukiwa, Toshihiro ;
Saijo, Yasuo .
MOLECULAR THERAPY, 2011, 19 (01) :196-203
[68]   Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation [J].
Kebir, Hania ;
Kreymborg, Katharina ;
Ifergan, Igal ;
Dodelet-Devillers, Aurore ;
Cayrol, Romain ;
Bernard, Monique ;
Giuliani, Fabrizio ;
Arbour, Nathalie ;
Becher, Burkhard ;
Prat, Alexandre .
NATURE MEDICINE, 2007, 13 (10) :1173-1175
[69]   Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa [J].
Kim, Doo-Jin ;
Kim, Kwang-Soon ;
Song, Mi-Young ;
Seo, Sang-Hwan ;
Kim, Su-Jin ;
Yang, Bo-Gie ;
Jang, Myoung-Ho ;
Sung, Young-Chul .
CLINICAL IMMUNOLOGY, 2012, 144 (03) :190-199
[70]   The Therapeutic Effects of Optimal Dose of Mesenchymal Stem Cells in a Murine Model of an Elastase Induced-Emphysema [J].
Kim, You-Sun ;
Kim, Ji-Young ;
Huh, Jin Won ;
Lee, Sei Won ;
Choi, Soo Jin ;
Oh, Yeon-Mok .
TUBERCULOSIS AND RESPIRATORY DISEASES, 2015, 78 (03) :239-245